FDA Warning Consumers About Side Effects of Benicar
Benicar Linked To Sprue-Like Enteropathy, Villous Atrophy, Signs of Celiac Disease
The Food and Drug Administration (FDA) has released a warning to consumers about the dangers of the drug Benicar (olmesartan medoxomil). The warning comes in response to reports of severe gastrointestinal (GI) conditions resulting from prolonged use of Benicar. Conditions include development of sprue-like enteropathy, characterized by chronic diarrhea and substantial weight loss.
Benecar Users Experiencing Serious Side Effects
Benicar has been shown to damage the lining of the intestines, making it more difficult or even impossible, to digest and absorb nutrients from food that is ingested. This causes severe, chronic diarrhea, significant weight loss, and malnourishment. These symptoms can lead to more gastrointestinal problems later in life. Studies have shown that patient’s conditions improved and symptoms subsided after discontinuing use of the drug.
Benicar Patient Help is Available
If you or someone you know is experiencing severe chronic diarrhea and extreme weight loss after taking Benicar, you may be entitled to compensation from the manufacturers of the drug. If you contracted villous atrophy, or exhibit the symptoms of Benicar side effects, contact an experienced Pennsylvania injury attorney at Handler Henning & Rosenberg for a free consultation about your legal options.